References
- Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994–1007
- Razzaque MS. Cisplatin nephropathy: is cytotoxicity avoidable? Nephrol Dial Transplant. 2007;22(8):2112–2126
- Jia Z, Wang N, Aoyagi T, Wang H, Liu H, Yang T. Amelioration of Cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. Kidney Int. 2011;79(1):77–88
- Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334(2):115–124
- Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in Cisplatin induced nephrotoxicity. Exp Toxicol Pathol. 2009;61(3):223–242
- Jung M, Hotter G, Vinas JL, Sola A. Cisplatin upregulates mitochondrial nitric oxide synthase and peroxynitrite formation to promote renal injury. Toxicol Appl Pharmacol. 2009;234(2):236–246
- Kawai Y, Nakao T, Kunimura N, Kohda Y, Gemba M. Relationship of intracellular calcium and oxygen radicals to Cisplatin-related renal cell injury. J Pharmacol Sci. 2006;100(1):65–72
- Satoh M, Kashihara N, Fujimoto S, et al. A novel free radical scavenger, edarabone, protects against Cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther. 2003;305(3):1183–1190
- Dennog C, Hartmann A, Frey G, Speit G. Detection of DNA damage after hyperbaricoxygen (HBO) therapy. Mutagenesis. 1996;11(6):605–609
- Rasoulian B, Jafari M, Mahbod M, et al. Pretreatment with oxygen protects rat kidney from Cisplatin nephrotoxicity. Ren Fail. 2010;32(2):234–242
- Atasoyu EM, Yildiz S, Bilgi O, et al. Investigation of the role of hyperbaric oxygen therapy in Cisplatin-induced nephrotoxicity in rats. Arch Toxicol. 2005;79(5):289–293
- Tinits P. Oxygen therapy and oxygen toxicity. Ann Emerg Med. 1983;12(5):321–328
- Tahepold P, Ruusalepp A, Li G, Vaage J, Starkopf J, Valen G. Cardioprotection by breathing hyperoxic gas-relation to oxygen concentration and exposure time in rats and mice. Eur J Cardiothorac Surg. 2002;21(6):987–994
- Rasoulian B, Mohammad hosseniakbari H, Kadkhodaee M, et al. Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury. J Surg Res. 2008;146(2):282–288
- Bigdeli MR, Rasoulian B, Meratan AA. In vivo normobaric hyperoxia preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue. Eur J Pharmacol. 2009;611(1–3):22–29
- Bigdeli MR, Khoshbaten A. In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-alpha converting enzyme/tumor necrosis factor-alpha/nuclear factor-kappaB. Neuroscience. 2008;153(3):671–678
- Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998;38(2):291–300
- Muralidharan V, Christophi C. Hyperbaric oxygen therapy and liver transplantation. HPB (Oxford). 2007;9(3):174–182
- Rubinstein I, Abassi Z, Milman F, et al. Hyperbaric oxygen treatment improves GFR in rats with ischemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischemic kidney. Nephrol Dial Transplant. 2009;24(2):428–436
- Han C, Lin L, Zhang W, et al. Hyperbaric oxygen preconditioning alleviates myocardial ischemic injury in rats. Exp Biol Med (Maywood). 2008;233(11):1448–1453
- Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovasc Revasc Med. 2010;11(1):8–19
- Yassuda CC, Righetti AE, Cury MC, Hyppolito MA, Oliveira JA, Feres O. The role of hyperbaric oxygen therapy (hot) as an otoprotection agent against Cisplatin ototoxicity. Acta Cir Bras. 2008;23(Suppl 1):72–76; discussion 6
- Corradini SG, Elisei W, De Marco R, et al. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl. 2005;11(2):140–151